RESUMO
Excess deaths from cardiovascular disease are a major contributor to the significant reduction in life expectancy experienced by people with schizophrenia. Important risk factors in this are smoking, alcohol misuse, excessive weight gain and diabetes. Weight gain also reinforces service users' negative views of themselves and is a factor in poor adherence with treatment. Monitoring of relevant physical health risk factors is frequently inadequate, as is provision of interventions to modify these. These guidelines review issues surrounding monitoring of physical health risk factors and make recommendations about an appropriate approach. Overweight and obesity, partly driven by antipsychotic drug treatment, are important factors contributing to the development of diabetes and cardiovascular disease in people with schizophrenia. There have been clinical trials of many interventions for people experiencing weight gain when taking antipsychotic medications but there is a lack of clear consensus regarding which may be appropriate in usual clinical practice. These guidelines review these trials and make recommendations regarding appropriate interventions. Interventions for smoking and alcohol misuse are reviewed, but more briefly as these are similar to those recommended for the general population. The management of impaired fasting glycaemia and impaired glucose tolerance ('pre-diabetes'), diabetes and other cardiovascular risks, such as dyslipidaemia, are also reviewed with respect to other currently available guidelines.These guidelines were compiled following a consensus meeting of experts involved in various aspects of these problems. They reviewed key areas of evidence and their clinical implications. Wider issues relating to primary care/secondary care interfaces are discussed but cannot be resolved within guidelines such as these.
Assuntos
Antipsicóticos/administração & dosagem , Doenças Cardiovasculares/prevenção & controle , Esquizofrenia/tratamento farmacológico , Antipsicóticos/efeitos adversos , Doenças Cardiovasculares/etiologia , Humanos , Doenças Metabólicas/etiologia , Doenças Metabólicas/terapia , Obesidade/etiologia , Obesidade/terapia , Sobrepeso/etiologia , Sobrepeso/terapia , Transtornos Psicóticos/complicações , Transtornos Psicóticos/tratamento farmacológico , Fatores de Risco , Esquizofrenia/complicações , Aumento de PesoRESUMO
OBJECTIVE: Acquiring a diagnosis of schizophrenia reduces life expectancy for many reasons including poverty, difficulties in communication, side-effects of medication and access to care. This mortality gap is driven by natural deaths; cardiovascular disease is a major cause, but outcomes for people with severe mental illness are worse for many physical health conditions, including cancer, fractures and complications of surgery. We set out to examine the literature on disparities in medical and dental care experienced by people with schizophrenia and suggest possible approaches to improving health. METHOD: This narrative review used a targeted literature search to identify the literature on physical health disparities in schizophrenia. RESULTS: There is evidence of inequitable access to and/or uptake of physical and dental health care by those with schizophrenia. CONCLUSION: The goal was to reduce the mortality gap through equity of access to all levels of health care, including acute care, long-term condition management, preventative medicine and health promotion. We suggest solutions to promote health, wellbeing and longevity in this population, prioritising identification of and intervention for risk factors for premature morbidity and mortality. Shared approaches are vital, while joint education of clinicians will help break down the artificial mind-body divide.
Assuntos
Assistência Odontológica/métodos , Assistência Odontológica/normas , Promoção da Saúde/métodos , Promoção da Saúde/normas , Assistência de Longa Duração/métodos , Esquizofrenia/terapia , Assistência Odontológica/organização & administração , Promoção da Saúde/organização & administração , Disparidades em Assistência à Saúde , Humanos , Expectativa de Vida , Assistência de Longa Duração/normas , Fatores de Risco , Esquizofrenia/epidemiologiaRESUMO
It is widely acknowledged that there is interplay between physical and mental health, with causality in both directions. A common theme across countries is the uncertainty surrounding who should act as gatekeeper for physical health matters in psychiatry. Much of the metabolic monitoring is carried out by psychiatrists who often feel ill equipped to treat medical problems such as abnormal cholesterol or disturbances of glucose metabolism. However many patients do not attend primary care on a regular basis and may not be likely to follow through on referral to primary care. This review aims to examine the interplay between co-morbid physical and mental health conditions, identify the physical health conditions particularly associated with severe affective and psychotic illness and briefly discuss interventions and recommendations in this area. As people with severe mental illness die 10-20 years younger than their peers, with much of this premature mortality due to cardiovascular disease, this topic is emerging as one of great importance amongst clinicians and policymakers internationally.